Skip to Content

Join the 'Chronic Obstructive Pulmonary Disease, Maintenance' group to help and get support from people like you.

Chronic Obstructive Pulmonary Disease, Maintenance News

Related terms: COPD, Maintenance

Bevespi Aerosphere Approved by the FDA for Patients with COPD

Posted 20 hours ago by Drugs.com

25 April 2016 – AstraZeneca today announced that the US Food and Drug Administration has approved Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) inhalation aerosol indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Sean Bohen, Executive Vice-President, Global Medicines Development and Chief Medical Officer, said: “With the approval of Bevespi Aerosphere we are pleased to provide patients with the first LAMA/LABA in a pressurised metered-dose inhaler, delivered using our unique formulation technology. LAMA/LABAs are emerging as a preferred treatment option for many COPD patients. This class aims to provide maximum bronchodilation, which enables patients to breathe better and may help them be more active.” Bevespi Aerosphere is a twice-daily, ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Glycopyrrolate, Formoterol, Bevespi Aerosphere, Formoterol/glycopyrrolate

Smog May Boost Risk for Several Cancers

Posted 1 day 5 hours ago by Drugs.com

FRIDAY, April 29, 2016 – Long-term exposure to fine particles of air pollution – from cars, trucks, power plants and manufacturing facilities – is tied to an increased risk of dying from several kinds of cancer, a new study suggests. "Air pollution remains a clear, modifiable public health concern," said researcher G. Neil Thomas, a reader in epidemiology at the University of Birmingham in England. "Put simply, the more of these particulates there are in the air, the greater the risk of getting these cancers," Thomas said, although the study did not prove the particles actually cause cancer. The study, involving more than 66,000 older residents of Hong Kong, found an increased risk of dying from cancer for even small increases in exposure to these tiny particles of air pollution, which are measured in micrograms per cubic meter (mcg/m3). For example, the overall risk of dying from ... Read more

Related support groups: Cancer, Cough, Smoking, Breast Cancer, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Upper Respiratory Tract Infection, Lung Cancer, Colorectal Cancer, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Toxic Reactions Incl Drug and Substance Abuse, Croup

Climate Change May Mean More Smoggy Days to Come: Study

Posted 9 days ago by Drugs.com

THURSDAY, April 21, 2016 – Climate change could cause many major American cities to experience more days with heavy ozone pollution in the coming decades, a new study predicts. If emission rates continue unchecked, regions within the United States could experience between three and nine additional days of unhealthy ozone levels between May and September by 2050, the study authors said. The researchers are concerned that climate change could undo the progress made under the Clean Air Act to rid U.S. skies of air pollution. "We found, in fact, that climate change could be a monkey wrench in our plans," said study co-author Loretta Mickley. She is a senior research fellow at Harvard's School of Engineering and Applied Sciences in Cambridge, Mass. "The number of bad ozone days per summer could double – could increase by as much as a week – by the 2050s," she said. California, the ... Read more

Related support groups: Cough, Asthma, Sinusitis, Chronic Obstructive Pulmonary Disease, Bronchitis, Pneumonia, Cold Symptoms, Chronic Obstructive Pulmonary Disease, Maintenance, Upper Respiratory Tract Infection, Asthma - Acute, Cough and Nasal Congestion, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Respiratory Tract Disease, Allergic Asthma, Croup, Bronchospastic Disease

Doctors Issue Call to Combat Climate Change

Posted 12 days ago by Drugs.com

MONDAY, April 18, 2016 – Climate change is already harming people's health by promoting illnesses linked to warmer temperatures and changing weather patterns, a leading group of U.S. doctors says in a new position paper. As a result, the American College of Physicians (ACP) is calling for "aggressive, concerted" action to fight climate change by curbing man-made greenhouse gas emissions. Respiratory illnesses, heat stroke and infectious diseases like Zika virus, dengue fever and cholera are flourishing as global temperatures rise, said Dr. Wayne Riley, president of the college. "Our climate is already changing and people are already being harmed. If we don't begin to address climate change, we're going to see more and more manifestations of these health problems," Riley said. "There is clear, compelling scientific consensus that climate change is real," he added. "There is no dispute." ... Read more

Related support groups: Depression, Anxiety and Stress, Migraine, Allergies, Asthma, Major Depressive Disorder, Post Traumatic Stress Disorder, Sinusitis, Chronic Obstructive Pulmonary Disease, Bronchitis, Migraine Prevention, Pneumonia, Asthma - Maintenance, Cold Symptoms, Chronic Obstructive Pulmonary Disease, Maintenance, Upper Respiratory Tract Infection, Dyspnea, Migraine Prophylaxis, Psychiatric Disorders, Asthma - Acute

Exercise May Extend Lives of People With COPD

Posted 19 Mar 2016 by Drugs.com

FRIDAY, March 18, 2016 – Regular exercise could help boost the survival of people who've left the hospital after battling chronic obstructive pulmonary disease (COPD), a new study finds. "We know that physical activity can have a positive benefit for people with COPD and these findings confirm that it may reduce the risk of dying following hospitalization," study lead author Dr. Marilyn Moy, assistant professor of medicine at Harvard Medical School, said in a news release from ERJ Open Research. Her team published the findings in the journal on March 16. COPD includes emphysema, chronic bronchitis or a combination of the two, and is often related to smoking. Common symptoms include difficulty breathing, chronic cough, wheezing and phlegm production. Over time, the condition can prove fatal. One expert, Dr. Alan Mensch, noted, "COPD is estimated to affect up to 7 percent of adults and ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute

Mom's Smoking May Put Kids at Higher Risk of COPD in Adulthood

Posted 11 Mar 2016 by Drugs.com

THURSDAY, March 10, 2016 – The children of mothers who smoke heavily may face a much higher risk for developing chronic obstructive pulmonary disease (COPD) as adults, new research suggests. The finding is based on the tracking of COPD risk among nearly 1,400 adults, and it suggests that heavy maternal smoking – more than 20 cigarettes per day – increases a child's long-term COPD risk nearly threefold. "The findings were not surprising to us," said study author Jennifer Perret. She is a postdoctoral fellow with the Centre for Air Quality and Evaluation in the Melbourne School of Population & Global Health at the University of Melbourne in Australia. "Smoking in later life can result in deficits in lung function by middle age. So it was not unexpected to see that mothers' smoking . . . could also adversely influence the growing lungs of [their children]," Perret said. And, "reduced ... Read more

Related support groups: Smoking, Chronic Obstructive Pulmonary Disease, Smoking Cessation, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute

Smog's Health Effects Persist for Decades, Study Finds

Posted 10 Feb 2016 by Drugs.com

TUESDAY, Feb. 9, 2016 – Air pollution can increase the risk of premature death, even decades later, one of the longest running air pollution studies suggests. British scientists found the negative health effects of air pollution – such as a higher risk of lung and heart disease – can persist for more than 30 years. The study authors suggested that more research into the long-term health effects of air pollution – often called smog – is needed. "Air pollution has well established impacts on health, especially on heart and lung disease," study author Dr. Anna Hansell, from Imperial College London, said in a university news release. "The novel aspects of our study are the very long follow-up time and the very detailed assessment of air pollution exposure, using air-quality measurements going back to the 1970s." The researchers monitored air pollution levels in areas of England and ... Read more

Related support groups: Cough, Heart Disease, Chronic Obstructive Pulmonary Disease, Bronchitis, Cold Symptoms, Chronic Obstructive Pulmonary Disease, Maintenance, Upper Respiratory Tract Infection, Dyspnea, Coronary Artery Disease (CAD), Prevention of Cardiovascular Disease, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Cardiovascular Risk Reduction, Respiratory Tract Disease, Respiratory Distress Syndrome, Croup, Ischemic Heart Disease, Vasomotor Rhinitis, Respiratory Failure, Reversible Airways Disease

Study Casts Doubt on Effectiveness of COPD Drug

Posted 2 Feb 2016 by Drugs.com

TUESDAY, Feb. 2, 2016 – A widely used drug may not significantly reduce the amount of time that patients with the lung condition COPD require mechanical help to breathe, a new study suggests. COPD (chronic obstructive pulmonary disease) – which is often related to smoking – includes emphysema, chronic bronchitis or a combination of the two. Common symptoms include difficulty breathing, chronic cough, wheezing and phlegm production. Over time, the condition can prove fatal. The drug acetazolamide has been used for decades to help COPD patients breathe when they develop a dangerous condition called metabolic alkalosis. However, the French study authors said that, until now, there's been no clinical trial to prove that the drug is actually effective in such cases. To try to remedy that situation, the new study included 380 French COPD patients who were expected to receive mechanical ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Diamox, Acetazolamide, Chronic Obstructive Pulmonary Disease, Acute, Bronchiectasis, Diamox Sequels

Implanted Lung Valves Show Promise in Some Emphysema Patients

Posted 9 Dec 2015 by Drugs.com

WEDNESDAY, Dec. 9, 2015 – New research suggests that more careful selection of patients could help improve the success rate of valves implanted into the lungs of people with emphysema. The valves aim to improve breathing, allowing patients with the chronic lung disease to be more active and to perhaps survive longer. Previous research into the valves has been mixed, but the new Dutch study found that they work more effectively if physicians are more selective about which patients get them. "The results are relatively impressive," said lung physician Dr. Gary Hunninghake, an assistant professor at Harvard Medical School in Boston. "These are benefits that physicians would want to get, and patients might feel better. This could result in people being more enthusiastic about this technique." However, the valves come with a risk of serious side effects, the study authors noted, and the ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Bronchitis, Chronic Obstructive Pulmonary Disease, Maintenance, Upper Respiratory Tract Infection, Chronic Obstructive Pulmonary Disease, Acute, Respiratory Tract Disease, Bronchiectasis, Diagnosis and Investigation, Respiratory Failure, Respiratory Arrest, Mechanical Ventilation, Bronchospastic Disease

Agricultural Pesticides May Affect Kids' Breathing

Posted 3 Dec 2015 by Drugs.com

THURSDAY, Dec. 3, 2015 – Early exposure to widely used pesticides may harm children's lungs, a new study says. Previous research has looked at the harmful effect of organophosphate pesticides – chemicals that target the nervous system – on adult agricultural workers. This new study looked at children living in an agricultural area where the organophosphates are used. "This is the first evidence suggesting that children exposed to organophosphates have poorer lung function," said study senior author Brenda Eskenazi, a professor of epidemiology and of maternal and child health at the University of California, Berkeley. For this study, researchers measured levels of organophosphate pesticides in urine samples collected on five occasions from 279 children in California's Salinas Valley between the ages of 6 months and 5 years. The area is an agricultural hub, producing lettuce, grapes, ... Read more

Related support groups: Cough, Asthma, Chronic Obstructive Pulmonary Disease, Bronchitis, Pneumonia, Asthma - Maintenance, Chronic Obstructive Pulmonary Disease, Maintenance, Upper Respiratory Tract Infection, Asthma - Acute, Sore Throat, Chronic Obstructive Pulmonary Disease, Acute, Respiratory Tract Disease, Bronchiectasis, Respiratory Distress Syndrome, Croup, Diagnosis and Investigation, Respiratory Failure, Reversible Airways Disease - Maintenance, Reversible Airways Disease

Pollution From Coal Burning Most Damaging to Health, Study Finds

Posted 2 Dec 2015 by Drugs.com

WEDNESDAY, Dec. 2, 2015 – Air pollution particles from the burning of coal are far more dangerous to your health than those from other sources, a new study indicates. Researchers analyzed data gathered from 450,000 people in 100 U.S. cities between 1982 and 2004. The team from NYU Langone Medical Center, in New York City, found that exposure to tiny particles in fossil fuel emissions are associated with an increased risk of heart disease. Fossil fuels include coal, crude oil and natural gas. The investigators found that – pound for pound – particles from coal burning contribute about five times more to the risk of death from heart disease than other air pollution particles of the same size – less than one ten-thousandth of an inch in diameter (known as PM 2.5). The findings were published online Dec. 2 in the journal Environmental Health Perspectives, just as world leaders gather in ... Read more

Related support groups: Cough, Smoking, Chronic Obstructive Pulmonary Disease, Maintenance, Cough and Nasal Congestion, Chronic Obstructive Pulmonary Disease, Acute, Respiratory Tract Disease, Reversible Airways Disease

FDA Approves Seebri Neohaler (glycopyrrolate) for COPD

Posted 4 Nov 2015 by Drugs.com

EAST HANOVER, N.J., Oct. 29, 2015 Novartis announced today that the US Food and Drug Administration (FDA) has approved Seebri Neohaler (glycopyrrolate) inhalation powder 15.6 mcg as a stand-alone monotherapy for COPD. Novartis expects that Seebri Neohaler will be available in the first quarter of 2016. Seebri is delivered via the low resistance Neohaler inhaler, which makes it suitable for patients with different severities of airflow limitation. About Seebri Neohaler Seebri Neohaler, previously known as NVA237, is a twice-daily long-acting muscarinic antagonist (LAMA) for the long-term maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema. Glycopyrrolate (also known as glycopyrronium bromide) was exclusively licensed to Novartis in April 2005 by Vectura and its co-development partner Sosei. About Novartis Respiratory ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Glycopyrrolate, Seebri Neohaler

FDA Approves Utibron Neohaler (indacaterol/glycopyrrolate) for COPD

Posted 4 Nov 2015 by Drugs.com

EAST HANOVER, N.J., Oct. 29, 2015 Novartis announced today that the US Food and Drug Administration (FDA) has approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated to treat asthma or sudden symptoms of COPD. "Patients have told us about the tremendous impact their COPD can have on everyday activities," said Christi Shaw, US Country Head, President of Novartis Corporation and Novartis Pharmaceuticals Corporation. "With this approval, the COPD community now has a new medicine that can help so many patients by improving not only their symptoms, but also their health-related quality of life. This means the possibility of doing things that matter ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Utibron Neohaler, Glycopyrrolate/indacaterol

Tai Chi Might Help People With Long-Term Health Conditions

Posted 17 Sep 2015 by Drugs.com

THURSDAY, Sept. 17, 2015 – The slow, fluid movements of tai chi – an ancient Chinese exercise – appear to help older adults with chronic conditions improve their physical function, a new review suggests. Specifically, those with breast cancer, heart failure, osteoarthritis or chronic obstructive pulmonary disease (COPD, which includes emphysema) saw improvements in strength, balance and posture without worsening pain or being out of breath, researchers said. "If you're older and have one of the conditions mentioned in the study, tai chi may be an alternative you can use to increase your fitness level," said senior researcher Darlene Reid, professor and chair of the Department of Physical Therapy at the University of Toronto in Canada. Tai chi is a series of gentle, flowing movements that aim to improve muscle power, balance, posture and flexibility, she said. In addition, tai chi has ... Read more

Related support groups: Osteoarthritis, Chronic Obstructive Pulmonary Disease, Breast Cancer, Heart Failure, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, Maintenance, Left Ventricular Dysfunction, Chronic Obstructive Pulmonary Disease, Acute, Breast Cancer, Prevention

No Evidence to Support Widespread Screening for COPD: Experts

Posted 17 Aug 2015 by Drugs.com

MONDAY, Aug. 17, 2015 – Chronic obstructive pulmonary disease (COPD) – a serious disease that impairs breathing – is the third leading cause of death in the United States. But an influential government panel says there's as yet no evidence to support screening for COPD in adults with no symptoms. In a draft recommendation released Monday, the U.S. Preventive Services Task Force said the panel had reviewed the latest evidence and saw no reason to change its earlier recommendation on COPD screening, issued in 2008. "The task force found that there is no evidence that screening for COPD in adults without symptoms results in improved health outcomes," member Dr. William Phillips said in a news release from the independent panel of experts. COPD includes emphysema, chronic bronchitis or a combination of the two. Common symptoms include difficulty breathing, chronic cough, wheezing and ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute

Page 1 2 3 4 Next

Ask a Question

Further Information

Related Condition Support Groups

Chronic Obstructive Pulmonary Disease

Related Drug Support Groups

albuterol, Symbicort, Spiriva, Ventolin, Advair Diskus, Advair HFA, Combivent, Xopenex, ProAir HFA, view more... Daliresp, ipratropium, Proventil, Atrovent, Breo Ellipta, salmeterol, Ventolin HFA, DuoNeb, tiotropium, glycopyrrolate, Proventil HFA, Maxair, Brovana, Alupent, Anoro Ellipta, formoterol, Tudorza Pressair, Atrovent HFA, Maxair Autohaler, Serevent Diskus, albuterol / ipratropium, Foradil Aerolizer, fluticasone / salmeterol, Tornalate, levalbuterol, Spiriva Respimat, Combivent Respimat, Stiolto Respimat, Perforomist, Seebri Neohaler, Utibron Neohaler, Ipratropium Inhalation Solution, Volmax, umeclidinium, umeclidinium / vilanterol, Xopenex HFA, pirbuterol, roflumilast, fluticasone / vilanterol, glycopyrrolate / indacaterol, aclidinium, AccuNeb, Incruse Ellipta, Vospire ER, olodaterol / tiotropium, ProAir RespiClick, Ipratropium Inhalation Aerosol, Metaprel, Respirol, Airet, metaproterenol, Xopenex Concentrate, budesonide / formoterol, arformoterol, indacaterol, bitolterol, Arcapta